CTOs on the Move

Anixa Biosciences

www.anixa.com

 
Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.anixa.com
  • 3150 Almaden Expressway
    San Jose, CA USA 95118
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Anixa Biosciences raised $10M on 03/22/2021

Similar Companies

Pendulum Therapeutics

Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of natural bacterial strains help to rebalance the microbiome which restores and improve one`s health.

CPS Instruments

CPS Instruments is a Stuart, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lexaria Bioscience

Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October, 2016. Lexaria`s technology provides increases of up to 10x in intestinal absorption rates; more rapid delivery to the bloodstream with effects often within 15-20 minutes; and important taste-masking benefits, for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.

Deepcell

Our mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease.

Genentech

Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009.